CellRev

CellRev provide bioprocessing solutions to increase the efficiency of cell manufacturing. Our products leverage application specific IP to address significant bottlenecks in cell culture protocols including aggregation, clumping, cell detachment, and process translatability. We support our customers to take breakthrough treatments from discovery to manufacturing. Our media additives permit productivity and cost improvements in existing batch, fed-batch, and perfusion based bioprocesses. CellRev also offer a pioneering continuous processing platform for adherent cells, the Livit ACE. The invent of this platform represents one of the most meaningful breakthroughs in adherent cell processing for decades. Whether developing a new process or improving...

Bioprocessing,adherent cell culture,process engineering,cell biology,cell growth,and high-density processing

Cellrev operates in the Biotechnology research industry.

Cellrev's revenue is 11m - 100m

Cellrev has 11 - 50 employees.